Gilteritinib (Xospata)

gilteritinib · Astellas Pharma

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Gilteritinib (Xospata), covering 2019-02-20 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML [Phase 1]